Queensland Guidelines for Antibiotics in Acute Bacterial Sinusitis
According to the most recent guidelines, high-dose amoxicillin-clavulanate (875/125 mg twice daily for adults) is the recommended first-line antibiotic treatment for acute bacterial sinusitis in Queensland. 1
First-Line Treatment Options
Adults:
- First choice: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
- High-dose option: 2000 mg amoxicillin component twice daily for 5-7 days (for severe cases or high-risk patients) 1
Children:
- First choice: Amoxicillin 45 mg/kg/day in 2 divided doses 2
- High-dose option: Amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate) in 2 divided doses for:
- Children younger than 2 years
- Those attending childcare
- Recent antibiotic use (within 4 weeks)
- Moderate to severe illness 2
Alternative Options for Penicillin-Allergic Patients
For patients with penicillin allergy, the following alternatives are recommended:
- Cefdinir 300 mg twice daily
- Cefpodoxime 200 mg twice daily
- Cefuroxime axetil 500 mg twice daily 1
Pathogens and Resistance Considerations
The main bacterial pathogens in acute bacterial sinusitis are:
Antimicrobial resistance patterns vary by region, with:
- 10-15% of S. pneumoniae isolates showing nonsusceptibility to penicillin nationally (up to 50-60% in some areas)
- 10-42% of H. influenzae and nearly 100% of M. catarrhalis producing β-lactamase 2
Treatment Duration
The recommended duration of treatment is 5-7 days 1. This shorter course is supported by evidence showing comparable efficacy to traditional 10-14 day regimens while potentially reducing antibiotic resistance and side effects.
Treatment Failure Protocol
If no improvement is observed after 72 hours of treatment:
- Reassess the diagnosis
- Consider switching to an alternative antibiotic
- Consider referral to a specialist if symptoms are worsening 1
Special Considerations
- Risk factors for resistant organisms: Recent antibiotic use (within 30 days), age younger than 2 years, and childcare attendance 2
- Severe cases: For patients unable to tolerate oral medication or with severe symptoms, a single 50 mg/kg dose of ceftriaxone (IV or IM) can be used initially 2
- Post-treatment follow-up: Patients should be reassessed within 3-5 days of starting treatment to evaluate effectiveness 1
Common Pitfalls to Avoid
Overdiagnosis: Distinguishing viral from bacterial sinusitis is crucial. Bacterial sinusitis should be suspected with:
- Persistent symptoms >10 days without improvement
- Severe symptoms with high fever and purulent discharge for 3-4 consecutive days
- Worsening symptoms after initial improvement
Inappropriate antibiotic selection: Using macrolides (clarithromycin, azithromycin) as first-line therapy is not recommended due to high rates of resistance among S. pneumoniae.
Inadequate dosing: Standard-dose amoxicillin may be insufficient in areas with high prevalence of resistant S. pneumoniae.
Premature treatment changes: Allow 72 hours for clinical response before considering a change in therapy.